Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5
Lidia Mosyak(Pfizer (United States)), W.S. Somers, Edward R. LaVallie(Boston University), Tod H. Marvell, Richard Zollner, Stewart A. Mackie, Erica Reifenberg, Phaik‐Eng Sum, Ronald Kriz, Laura Lin(Pfizer (United States)), Xiaotian Zhong(Pfizer (United States)), Matthew D. Vera, Lisa A. Collins‐Racie, Tania Shane, Bethany A. Freeman, Mark Stahl, Kristine Svenson, Tracy Hebert, Thomas McDonagh, Katy E. Georgiadis, Christopher Corcoran, Stéphane Olland
Cited by 142
Related Papers
A Shape-Based 3-D Scaffold Hopping Method and Its Application to a Bacterial Protein−Protein Interaction
|Journal of Medicinal Chemistry|2005|605
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
|Annals of Neurology|2008|466